Literature DB >> 11951581

Benefits of resveratrol in women's health.

D Bagchi1, D K Das, A Tosaki, M Bagchi, S C Kothari.   

Abstract

Resveratrol and trans-resveratrol are powerful phytoestrogens, present in the skins of grapes and other plant foods and wine, which demonstrate a broad spectrum of pharmacological and therapeutic health benefits. Phytoestrogens are naturally occurring plant-derived nonsteroidal compounds that are functionally and structurally similar to steroidal estrogens, such as estradiol, produced by the body. Various studies, reviewed herein, have demonstrated the health benefits of phytoestrogens in addressing climacteric syndrome including vasomotor symptoms and postmenopausal health risks, as well as their anticarcinogenic, neuroprotective and cardioprotective activities and prostate health and bone formation promoting properties. Conventional HRT drugs have been demonstrated to cause serious adverse effects including stroke and gallbladder disease, as well as endometrial, uterine and breast cancers. Recent research demonstrates that trans-resveratrol binds to human estrogen receptors and increases estrogenic activity in the body. We investigated the effects of protykin, a standardized extract of trans-resveratrol from Polygonum cuspidatum, on cardioprotective function, the incidence of reperfusion-induced arrhythmias and free radical production in isolated ischemic/reperfused rat hearts. The rats were orally treated with two different daily doses of protykin for 3 weeks. Coronary effluents were measured for oxygen free radical production by electron spin resonance (ESR) spectroscopy in treated and drug-free control groups. In rats treated with 50 and 100 mg/kg of protykin, the incidence of reperfusion-induced ventricular fibrillation was reduced from its control value of 83% to 75% (p < 0.05) and 33% (p < 0.05), respectively. Protykin was seen to possess cardioprotective effects against reperfusion-induced arrhythmias through its ability to reduce or remove the reactive oxygen species in ischemic/reperfused myocardium. Taken together, these data suggest that trans-resveratrol supplementation may be a potential alternative to conventional HRT for cardioprotection and osteoporosis prevention and may confer other potential health benefits in women.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11951581

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  5 in total

1.  Uptake of resveratrol and role of resveratrol-targeting protein, quinone reductase 2, in normally cultured human prostate cells.

Authors:  Tze-Chen Hsieh
Journal:  Asian J Androl       Date:  2009-09-21       Impact factor: 3.285

2.  Effects of resveratrol on bone mineral density in ovarectomized rats.

Authors:  Qian Lin; Yi-Ming Huang; Ben-Xi Xiao; Guo-Feng Ren
Journal:  Int J Biomed Sci       Date:  2005-06

Review 3.  Phytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspective.

Authors:  Elisabetta Poluzzi; Carlo Piccinni; Emanuel Raschi; Angela Rampa; Maurizio Recanatini; Fabrizio De Ponti
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

4.  Long-Term Resveratrol Supplementation as a Secondary Prophylaxis for Stroke.

Authors:  Katalin Fodor; Delia Mirela Tit; Bianca Pasca; Cristiana Bustea; Diana Uivarosan; Laura Endres; Ciprian Iovan; Mohamed M Abdel-Daim; Simona Bungau
Journal:  Oxid Med Cell Longev       Date:  2018-03-18       Impact factor: 6.543

5.  Estrogenic Effect of Scoparia dulcis (Linn) Extract in Mice Uterus and In Silico Molecular Docking Studies of Certain Compounds with Human Estrogen Receptors.

Authors:  Khamhee Wangsa; Indira Sarma; Purbajyoti Saikia; Dhanabalan Ananthakrishnan; Hirendra Nath Sarma; Devadasan Velmurugan
Journal:  J Reprod Infertil       Date:  2020 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.